Can gene editing truly support smallholder farmers and help Indonesia achieve food sovereignty, or will it simply revive the ...

Actio Biosciences, a clinical-stage biotechnology company advancing the translation of genetic insights into novel precision ...

Sana Biotechnology advances engineered cell therapies as nasdaq 100 composition discussions highlight innovative biopharmaceutical firms.

In recent days, Cathie Wood’s ARK Invest has materially increased its holdings in Beam Therapeutics, adding more than 195,000 shares across its genomics-focused funds as it leans further into ...

Chromatin Bioscience, Mediphage Bioceuticals, and Entos Pharmaceuticals are pleased to announce they are receiving advisory ...

SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in ...

For decades, diagnosing a mental illness has depended largely on symptoms and clinical observation rather than lab tests. Yet ...

24/7 Market News (247) is a leading market news platform for public companies. As a pioneer in digital media, 247 is dedicated to the swift distribution of financial market news and information. 247 ...

An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...

PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...

A collaborative team of researchers from the Donald Danforth Plant Science Center, the University of Florida, Gainesville and ...

Alloy Therapeutics today announced the appointment of Christian Cobaugh, Ph.D., as Chief Executive Officer of Alloy Genetic Medicines. Through its partnerships, the Genetic Medicines division is ...